Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ER.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ER.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ER.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ER.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ER.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.16.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.16.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.16.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.372EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.372ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.372ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.372EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.372EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.425EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.425EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.425ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.425ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.425EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used